21 January 2018
News and Views
Links and Services
FibroTest is an independent predictor of virologic response in chronic HCV patients retreated with pegylated interferon alfa-2b and ribavirin, finds February's Journal of Hepatology.
EPIC-3 is a prospective, international study that has demonstrated the efficacy of pegylated-inte
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors